Cargando…
Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor
BACKGROUND: Premenopausal women with high-risk hormone receptor (HR)-positive breast cancer often receive ovarian function suppression (OFS) with aromatase inhibitor therapy; however, abrupt menopause induction, together with further decrements in estrogen exposure through aromatase inhibition, may...
Autores principales: | Jordan, Jennifer H, D’Agostino, Ralph B, Ansley, Katherine, Douglas, Emily, Melin, Susan, Sorscher, Steven, Vasu, Sujethra, Park, Sung, Kotak, Anuj, Romitti, Paul A, O’Connell, Nathanial S, Hundley, William G, Thomas, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406435/ https://www.ncbi.nlm.nih.gov/pubmed/34476341 http://dx.doi.org/10.1093/jncics/pkab071 |
Ejemplares similares
-
Dispersion of hyperenhancement in late gadolinium enhancement cardiovascular magnetic resonance measured with Moran's I is associated with a decrement in LVEF 6 months after cardiotoxic chemotherapy
por: Jordan, Jennifer H, et al.
Publicado: (2013) -
Simultaneous Left Ventricular Volume and Strain Changes During Chemotherapy Associate With 2‐Year Postchemotherapy Measures of Left Ventricular Ejection Fraction
por: Suerken, Cynthia K., et al.
Publicado: (2020) -
Chronic Statin Administration May Attenuate Early Anthracycline Associated Declines in Left Ventricular Ejection Function
por: Chotenimitkhun, Runyawan, et al.
Publicado: (2014) -
Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013) -
Cardiovascular Magnetic Resonance in the Oncology Patient
por: Jordan, Jennifer H., et al.
Publicado: (2018)